Skip to main content
Clinical Trials/CTRI/2018/12/016579
CTRI/2018/12/016579
Not yet recruiting
未知

Quantification of Immune Cell Types and Identification of Cell-Type Specific Biomarker Expression in Pulmonary and Extra-Pulmonary Tuberculosis Patients: a pilot study

Public Health England0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Public Health England
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • Group 1: All geneXpert positive newly diagnosed treatment naive adult patients ( \>18 years of age) with pulmonary tuberculosis diagnosed at the Microbiology department
  • Group 2: All geneXpert positive newly diagnosed treatment naive adult patients ( \>18 years of age) with extra pulmonary tuberculosis diagnosed at the Microbiology department
  • Group 3: Bacteriologically confirmed cases of Pneumonia.
  • Group 4: Healthy volunteers who are negative for Tuberculin Skin Test or Interferon Gamma Release Assay (to rule out latent TB)

Exclusion Criteria

  • HIV positive
  • Patients on steroids or other immunosuppressive drugs
  • Pregnant women

Outcomes

Primary Outcomes

Not specified

Similar Trials